CPC of America

CPC of America, Inc. was a medical device company focused on the development and commercialization of proprietary technologies for the treatment of cardiovascular disease. The company's primary product, the Med-Pro system, was a catheter-based device designed for the removal of plaque and thrombus from the vascular system. Headquartered in Sarasota, Florida, the company targeted the interventional cardiology and peripheral vascular markets with its minimally invasive solutions. Despite obtaining regulatory clearances for its core technology, the company faced financial challenges and eventually ceased operations. CPC of America is currently considered an inactive entity, and its shares are no longer actively traded on major public exchanges.